3 Topic Commentaries

ACS report: Lung cancer deaths plunge as survival doubles

• 

  Dawn Hershman, MD, MS, FASCO

  Medical Oncology

  •

  Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center

  On the positive side, five-year survival for advanced-stage lung cancer has improved substantially since the mid-1990s, reflecting advances in targeted therapies and immunotherapy.

  Source
• 

  Julie R. Brahmer, MD

  Thoracic Medical Oncology

  •

  Johns Hopkins Kimmel Cancer Center

  Five-year overall survival quadrupled in non-small cell lung cancer, compared with what we would expect from chemotherapy.

  Source
• 

  William G. Nelson, MD, PhD

  Medical Oncology

  •

  Johns Hopkins Medicine

  Big news that's exciting is the five year survival rate for all cancers it's now 70%, that's double of what it was in the 1970s.

  Source